Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 969.00
Bid: 964.00
Ask: 969.00
Change: -14.00 (-1.42%)
Spread: 5.00 (0.519%)
Open: 987.00
High: 990.00
Low: 963.00
Prev. Close: 983.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

22 Jun 2023 07:00

RNS Number : 4804D
CVS Group plc
22 June 2023
 

For Immediate Release

22 June 2023

 

CVS Group plc("CVS", the "Company" or the "Group")

Appointments of non-executive director and Deputy CEO

CVS, the quoted provider of integrated veterinary services, is pleased to announce the appointment of Joanne Shaw as Non-executive Director with effect from 1 July 2023. 

 

Joanne Mary Shaw (59), has significant healthcare experience from her current roles as Trustee and Audit Committee Chair at Cancer Research UK, Chair at the Royal College of Paediatrics and Child Health, and Deputy Chair at Vitality UK. She has held a number of previous non-executive roles over the past 17 years including as non-executive director and Chair of the Audit and Risk Committee at NHS England and the National Audit Office, Chair of NHS Direct, Non-executive Director at Kensington and Chelsea Primary Care Trust and Chair of the British Equestrian Association. Joanne, who qualified as a chartered accountant, was a former management consultant at Boston Consulting Group and has previous executive roles at the Medicines Partnership, the Audit Commission and Coopers & Lybrand.

 

In her role of Non-executive Director, Joanne will become a member of the Audit, Remuneration and Nominations committees of the Board.

 

The Board is also pleased to announce the appointment of Ben Jacklin, Chief Operating Officer, to a newly created role of Deputy CEO, also with effect from 1 July 2023. Ben will retain responsibility for leading the Group's operations in the UK and internationally.

 

Chairman Richard Connell commented:

 

"On behalf of the Board I am delighted to welcome Joanne Shaw as a Non-executive Director. Her extensive healthcare experience will support the Board and the wider Group in delivering its purpose to provide the best possible care to animals. The Board looks forward to her input and to working together to deliver further success for the Group.

 

I am also delighted to congratulate Ben Jacklin on his promotion to Deputy CEO which is a reflection of Ben's significant contribution to the Group over the past few years."

 

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, COO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell +44 (0)7789 151 644

 

 

 

Additional Disclosures under the AIM Rules for Companies:

 

In relation to the appointment of Joanne Shaw, aged 59:

 

Current directorships/partnerships Past directorships/partnerships

Royal College of Paediatrics & Child Health NHS England

Cancer Research UK Nuffield Health

Cancer Research UK Trading Ltd Discovery Holdings Europe Ltd

Imperial Cancer Research Fund

Vitality Corporate Services Ltd

Vitality Health Ltd

Vanguard Metropolitan Ltd

 

At the date of this announcement Joanne Shaw does not hold any ordinary shares in the Company.

 

Save for the above, there are no further disclosures to be made in accordance with Rule 17 and 2 paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUAVAROWUNUAR
Date   Source Headline
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments
29th Nov 20197:00 amRNSResult of AGM
28th Nov 20197:00 amRNSAnnual General Meeting Statement
21st Nov 201910:15 amRNSHolding(s) in Company
20th Nov 20197:00 amRNSHolding(s) in Company
11th Nov 20199:19 amRNSHolding(s) in Company
8th Nov 201912:13 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSChange of CEO and Other Directorate Changes
5th Nov 20195:53 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSPosting of AR, Notice of AGM & Dividend Timetable
1st Nov 20195:38 pmRNSHolding(s) in Company
31st Oct 20194:33 pmRNSExercise of Options and Total Voting Rights
18th Oct 20199:16 amRNSHolding(s) in Company
9th Oct 201911:16 amRNSHolding(s) in Company
8th Oct 20196:12 pmRNSDirector/PDMR and PCA Shareholding
2nd Oct 201910:06 amRNSHolding(s) in Company
30th Sep 20194:14 pmRNSExercise of Options and Total Voting Rights
27th Sep 20197:00 amRNSPreliminary Results for year ended 30 June 2019
25th Sep 201912:42 pmRNSHolding(s) in Company
24th Sep 201910:34 amRNSHolding(s) in Company
12th Sep 20194:33 pmRNSHolding(s) in Company
12th Sep 20192:50 pmRNSHolding(s) in Company
12th Sep 20199:48 amRNSHolding(s) in Company
11th Sep 20193:42 pmRNSHolding(s) in Company
10th Sep 20193:46 pmRNSHolding(s) in Company
4th Sep 20192:15 pmRNSHolding(s) in Company
2nd Sep 20195:37 pmRNSHolding(s) in Company
2nd Sep 20199:22 amRNSHolding(s) in Company
30th Aug 20192:51 pmRNSExercise of Options and Total Voting Rights
29th Aug 20195:38 pmRNSHolding(s) in Company
22nd Aug 201910:23 amRNSHolding(s) in Company
12th Aug 20194:53 pmRNSHolding(s) in Company
12th Aug 20199:21 amRNSHolding(s) in Company
8th Aug 201911:34 amRNSHolding(s) in Company
5th Aug 20199:12 amRNSHolding(s) in Company
1st Aug 20197:00 amRNSExercise of Options and Total Voting Rights
26th Jul 20197:00 amRNSTrading Update
16th Jul 20199:55 amRNSHolding(s) in Company
11th Jul 20195:38 pmRNSHolding(s) in Company
11th Jul 201910:57 amRNSHolding(s) in Company
9th Jul 20194:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.